Blockade of the VEGF pathway with mAbs

Blockade of the VEGF pathway with mAbs. The specificity of the VEGF family ligands for the VEGF receptors and coreceptors are shown. The clinically-relevant mAbs targeting the anti-VEGF pathway discussed in this review are placed based on their blockade of VEGF ligand or receptor. The ligand-binding antibodies bevacizumab (bev), r84, and VEGF-Trap inhibit ligand binding to the indicated receptor. IMC-18F1 and IMC-1121B bind VEGFR1 and VEGFR2 respectively, and prevent ligand binding.
Blockade of the VEGF pathway with mAbs

Publication

The VEGF family in cancer and antibody-based strategies for their inhibition. (2010) Laura A Sullivan, et al. MAbs. 2010 Mar-Apr;2(2):165-175. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates VEGF-A VEGFA ncbigene_symbol VEGFA 7422
Homo sapiens Primates VEGF-B VEGFB ncbigene_symbol VEGFB 7423
Homo sapiens Primates VEGF-C VEGFC ncbigene_symbol VEGFC 7424
Homo sapiens Primates PIGF PIGF ncbigene_symbol PIGF 5281
Homo sapiens Primates PIGF PIGF ncbigene_synonym PGF 5228
Homo sapiens Primates VEGF-D VEGF-D ncbigene_synonym VEGFD 2277
Homo sapiens Primates Npn1,2 NPN2 ncbigene_synonym NRP2 8828
Homo sapiens Primates VEGFR1 VEGFR1 ncbigene_synonym FLT1 2321
Homo sapiens Primates VEGFR2 VEGFR2 ncbigene_synonym KDR 3791

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID